|
FOR
IMMEDIATE RELEASE
July
10, 2007.
Activotec
selected the recent 20th American Peptide Society Symposium in Montreal,
Canada, for the North American launch of its Activo-P11 Peptide
Synthesiser.
Efficient,
high speed synthesis of complex peptides ...
Activotec
selected the recent 20th American Peptide Society Symposium in Montreal,
Canada, for the North American launch of its Activo-P11 Peptide
Synthesiser.

The
Activo-P11 Peptide Synthesiser is an easy to use and affordable
instrument for synthesis of very high quality peptides. The fully
automated and enclosed system performs a wide range of chemistries
to synthesise peptides of any length in the 0.1 - 1.0 mmol. scale.
Combined with very easy-to-use software, designed by chemists for
chemists, the Activo-P11 was one of the most visited attractions
at the exhibition accompanying the symposium.
Particular
interest was also shown in a technical poster describing a new all-solid
phase approach using the Activo-P11 for synthesising cyclic peptide
chitinase inhibitors as potential new leads for antifungal and anti-inflammatory
drugs. Based upon work by UK researchers from the Department of
Pharmacy & Pharmacology, University of Bath and the College
of Life Sciences, University of Dundee the entirely on-resin synthesis
on the Activo-P11 demonstrated significant improvements in speed
and efficiency over traditional approaches.
Activotec,
which has its trading base in Cambridge (UK) and an R&D and
production facility in Southampton (UK), was founded in 2002 as
a spin out from the internationally renowned School of Biological
Sciences at the University of Southampton. Activotec is a customer-focused
company providing high technology products and services for chemistry
and biochemistry applications. Activotec provides a complete range
of products and services for peptide and protein synthesis.
For
further information on the Activo-P11 peptide synthesiser or a copy
of the technical poster please contact Activotec
CONTACTS:
|